Stay updated with breaking news from Jacobs Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Argonautica Private Wealth Management Inc. bought a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) in the fourth quarter, Holdings Channel.com reports. The fund bought 39,914 shares of the biopharmaceutical company’s stock, valued at approximately $3,427,000. Gilead Sciences makes up about 1.8% of Argonautica Private Wealth Management Inc.’s holdings, making the […]
Bowen Hanes & Co. Inc. bought a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 17,775 shares of the biopharmaceutical company’s stock, valued at approximately $1,526,000. A number of other large investors have […]
Dorsey & Whitney Trust CO LLC grew its position in Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 1.4% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 12,462 shares of the biopharmaceutical company’s stock after purchasing an additional 178 shares during the quarter. Dorsey & Whitney Trust CO LLC’s holdings in Gilead […]
Prudential PLC lifted its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 23.5% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 226,009 shares of the biopharmaceutical company’s stock after buying an additional 43,068 shares during the quarter. Prudential PLC’s holdings […]
Alpha Family Trust purchased a new stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 7,435 shares of the biopharmaceutical company’s stock, valued at approximately $638,000. Other hedge funds and […]